HOME >> MEDICINE >> NEWS
Use of antibiotic to treat infectious eye disease trachoma may increase risk for reinfection

Use of the antibiotic azithromycin to treat trachoma in Vietnam resulted in an increase in the risk of re-infections, according to a study in the September 27 issue of JAMA.

In 1995, the World Health Organization (WHO) first published data on global blindness and reported that 15 percent of cases were due to trachoma (a contagious bacterial eye disease in which scar tissue forms inside the eyelid and causes infection), making it the second major cause of blindness after cataract. At that time, the WHO estimated that 146 million individuals were in need of treatment for active trachoma to prevent blindness, 10 million were in need of surgery for trachomatous trichiasis (eyelash[es] touching the eye), and 8 million were already blind, according to background information in the article.

In 1996, the WHO designed the SAFE (Surgery for trachomatous trichiasis; Antibiotics for Chlamydia trachomatis (a type of Chlamydia that causes trachoma); Facial cleanliness; and Environmental improvement) strategy with the goal of elimination of blinding trachoma by the year 2020. For the antibiotic arm of the SAFE strategy, the WHO has recommended antibiotic treatment with either topical tetracycline or oral azithromycin for certain categories of patients with active trachoma. Oral azithromycin has become the drug of choice for the SAFE programs because of difficulties concerning administration and adherence with topical tetracycline eye ointment. Despite a number of studies, there has been a lack of sufficient follow-up beyond the final treatment point to determine rates of recurrence of disease and infection and the risk factors that may contribute to each.

Berna Atik, M.D., M.P.H., of Children's Hospital Oakland Research Institute, Oakland, Calif., and colleagues evaluated the effect of targeted oral azithromycin treatment of school age children and their household members in Vietnam on active trachoma and C trachomatis infection rates. Vietnam is
'"/>

Contact: Venita Robinson
510-428-3069
JAMA and Archives Journals
26-Sep-2006


Page: 1 2

Related medicine news :

1. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
2. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
3. Plants uptake antibiotics
4. Community-associated staph infections involving antibiotic-resistant bacteria increase
5. Researchers discover how antibiotic inhibits bacterial growth
6. Study finds antibiotic resistance in poultry even when antibiotics were not used
7. Rapid flu testing is associated with decreased antibiotic use in hospitalized adults
8. Rapid flu tests may reduce threat of antibiotic resistance
9. Antibiotic ear drops favored over popular oral antibiotics for ear infections
10. Controlling antibiotics and antibiotic resistance in hospitals
11. Transmission of antibiotic-resistant bacteria linked to previous intensive care unit room occupants

Post Your Comments:
(Date:8/31/2015)... ... ... MeYou Health ®, a social well-being company and wholly owned subsidiary of Healthways, ... in-app step tracker. , Walkadoo is a pedometer-based walking program that provides ... every Walkadoo member 10,000 steps a day (as is typical for many walking programs), ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s big news for ... digital healthcare industry. , Consumer driven health plans (CDHPs) are a growing phenomenon, ... and strategic role to the company, and another to answer customers’ questions directly. , ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Brooks Group, a ... , a department devoted to helping organizations identify and keep the best talent ... and The Brooks Group believes in offering a solution that goes beyond simply ...
(Date:8/31/2015)... ... ... Now here’s some good health news: Nearly two-thirds of Americans say they ... with the majority of Americans eating more whole grains than they did five years ... findings and others from the 2015 Whole Grains Consumer Insights Survey in time for ...
(Date:8/31/2015)... ... August 31, 2015 , ... Now through October 31st, ... will be featured on a digital screen projected above New York’s Times Square, ... and promote earlier awareness of the symptoms of ovarian cancer, and earlier conversations ...
Breaking Medicine News(10 mins):Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 3
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... The scientific team of a new biotech company ... academics in the field of aging Prof. Robert J. ... for model animals - 10 fold for nematodes) has recently ... primarily, around the stability and stress resistance of certain gene ... analysis of a model gene network links aging, stress resistance, ...
(Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company plc ... the Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder ... "Our views of Mylan,s offer to Perrigo ... based on our Board,s careful reflection of the value ... the limited choices that Mylan has allowed its shareholders ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
Cached News: